Risperidone and pituitary adenomas.

Detalles Bibliográficos
Publicado en:Australian & New Zealand Journal of Psychiatry Vol. 43; no. 2; pp. 177 - 178
Autores principales: Sainani A, Cabral S
Formato: case study letter Journal Article
Publicado: Sage Publications Inc. Feb2009
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105631168&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105631168
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00048674
        7ZU
      jtl: Australian & New Zealand Journal of Psychiatry
      issn: 00048674
      maglogo: Y
    pubinfo:
      dt: Feb2009
      vid: 43
      iid: 2
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        105631168
        105631168
        2010171550
        NLM19172671
        105631168
      ppf: 177
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Risperidone and pituitary adenomas.
      aug:
        au:
          Sainani A
          Cabral S
      sug:
        subj:
          Pituitary Neoplasms Etiology
          Risperidone Adverse Effects
          Adult
          Female
          Middle Age
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
      pubtype: Academic Journal
      doctype:
        case study
        letter
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N